Sponsored Seminar
Luncheon Seminar Program
September 30th (Thu)
L Live, O On-demand
LS1 Eli Lilly Japan K.K.L
- September 30th (Thu) 11:50~12:40(Second venue)PACIFICO Yokohama 3rd floor Room 301
- Chair:Katsuyuki Kiura(Department of Allergy and Respiratory Medicine, Okayama University Hospital)
- Treatment strategies for diversified driver gene mutation positive NSCLC・Diagnostic aspects
- Speaker 1:Kengo Takeuchi(Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research)
- Treatment strategies for diversified driver gene mutation positive NSCLC・Clinical aspects
- Speaker 2:Makoto Nishio(Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research)
LS2 Nippon Becton Dickinson Company, Ltd. L O
- September 30th (Thu) 11:50~12:40(Third venue)PACIFICO Yokohama 3rd floor Room 302
- Chair:Takuya Yamamoto(National Institutes of Biomedical Innovation, Health and Nutrition, Laboratory of Immunosenescence)
- “Bedside to Bench and Back” – The Innovative Cancer Immunological Research by the High-Dimensional Single-Cell Analysis of Surgical Resected Samples
- Speaker:Hirofumi Akita(Department of Gastroenterological Surgery, Osaka International Cancer Institute)
LS3 SymBio Pharmaceuticals, Ltd.
- September 30th (Thu) 11:50~12:40(4th venue)PACIFICO Yokohama 3rd floor Room 303
- Chair:Akifumi Takaori(Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University)
- Treatment strategies for relapsed or refractory diffuse large B-cell lymphoma
- Speaker:Itaru Matsumura(Department of Hematology and Rheumatology, Kindai University Faculty of Medicine)
LS4 Scrum Inc.L O
- September 30th (Thu) 11:50~12:40(5th venue)PACIFICO Yokohama 3rd floor Room 304
- Chair:Tomoshi Kakeya(Scrum Inc.)
- Assay Solutions for Confident Decision Making in Targeted Therapeutics Development
~ From high-throughput signaling protein expression analysis to immuno-cell killing assay~ - Speaker:Toru Hattori(Strategic Marketing Division, Scrum Inc.)
LS5 Novocure Ltd.O
- September 30th (Thu) 11:50~12:40(7th venue)PACIFICO Yokohama 3rd floor Room 311+312
- Chair:Hideo Nakamura(Department of Neurosurgery, Kurume University Hospital)
- Tumor Treating Fields : from the Petri dish to the Patient
- Speaker:Moshe Giladi(Senior Director of Preclinical, Novocure Ltd)
LS6 AstraZeneca K.K.
- September 30th (Thu) 11:50~12:40(8th venue)PACIFICO Yokohama 3rd floor Room 313+314
- Chair:Hideaki Miyake(Department of Urology, Hamamatsu University School of Medicine)
- Cancer Precision Medicine in Prostate Cancer
- Speaker:Shusuke Akamatsu(Department of Urology, Kyoto University Graduate School of Medicine)
LS7 Eisai Co., Ltd.L
- September 30th (Thu) 11:50~12:40(9th venue)PACIFICO Yokohama 4rd floor Room 411+412
- Chair:Koichi Akashi(Department of Medicine and Biosystemic Science, Graduate School of Medical Science, Kyushu University)
- Epigenetic abnormalities in B-cell lymphoma
- Speaker:Momoko Nishikori(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
LS8 Leica Microsystems K.K.
- September 30th (Thu) 11:50~12:40(11th venue)PACIFICO Yokohama 4rd floor Room 414+415
- Chair:Shintaro Tanaka(Leica Microsystems K.K., LSR Division)
- Proteogenomics Analysis with LMD for Oncology
- Speaker 1:Nobuhide Tsurumaki(Leica Microsystems K.K., LSR Division)
- Cell DIVE Multiplex Imaging Solution for Precision Oncology
- Speaker 2:Toshiyuki Hatano(Leica Microsystems K.K., LSR Division)
LS9 TAIHO PHARMACEUTICAL CO., LTD.
- September 30th (Thu) 11:50~12:40(12th venue)PACIFICO Yokohama 4rd floor Room 416+417
- Chair:Yukio Hosomi(Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan)
- Lung cancer chemotherapy updates
- Speaker:Hiroyuki Yasuda(Division of Pulmonary Medicine, Keio University, School of Medicine)
LS10 Novartis Pharma K.K. L
- September 30th (Thu) 11:50~12:40(13th venue)PACIFICO Yokohama 4rd floor Room 418
- Chair:Keisuke Kataoka(Division of Hematology, Department of Medicine, Keio University School of Medicine)
- Clinical practice in CAR-T cell therapy
- Speaker:Jun Kato(Division of Hematology, Department of Medicine, Keio University School of Medicine)
LS11 Invitae Japan K.K.O
- September 30th (Thu) 11:50~12:40(15th venue)PACIFICO Yokohama 5rd floor Room 501
- Chair:Nahoko Sakai(Invitae Japan K.K.)
- Invitae Liquid Biopsy Solutions: LiquidPlex™ and Personalized Cancer Monitoring (PCM™)
- Speaker:Vishal Sikri(Invitae corporation)
October 1st (Fri)
LS12 Takeda Pharmaceutical Co., Ltd.L
- October 1st (Fri) 11:50~12:40(First venue)PACIFICO Yokohama 1th floor Main hall
- Chair:Hirotsugu Uemura(Department of Urology, Kindai University Faculty of Medicine)
- Optimal therapeutic strategy for advanced renal cell carcinoma in the era of combined immunotherapy
- Speaker:Hideaki Miyake(Department of Urology, Hamamatsu University School of Medicine)
LS13 Otsuka Pharmaceutical Co., Ltd. L
- October 1st (Fri) 11:50~12:40(Second venue)PACIFICO Yokohama 3rd floor Room 301
- Chair:Hideaki Nakajima(Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine)
- Current status and future prospects of the cancer immunotherapy; focus on the relationship between cancer cells and immune cells
- Speaker:Hiroyoshi Nishikawa(Division of Cancer Immunology, Research Institute/ Exploratory Oncology Research & Clinical Trial Center National Cancer Center)
LS14Illumina K.K. O
- October 1st (Fri) 11:50~12:40(Third venue)PACIFICO Yokohama 3rd floor Room 302
- Chair:Hideki Hanaoka(Regional Segment Marketing Department, Asia Pacific and Japan, Illumina)
- Revolution in Cancer Genomic Medicine
- Speaker:Yusuke Nakamura(Cancer Precision Medicine Center, Japanese Foundation for Cancer Research)
LS15Chugai Pharmaceutical Co., Ltd.L
- October 1st (Fri) 11:50~12:40(4th venue)PACIFICO Yokohama 3rd floor Room 303
- Chair:Eishi Baba(Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University)
- How to utilize comprehensive genomic profiling test for daily clinical practice
- Speaker:Masashi Kanai(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
LS16Mitsubishi Space Software Co., Ltd. O
- October 1st (Fri) 11:50~12:40(5th venue)PACIFICO Yokohama 3rd floor Room 304
- Chair:Mototsugu Oya(Department of Urology, Keio University School of Medicine)
- PleSSision-Rapid; a cancer genomic screening test promote precision cancer medicine in Keio University Hospital
- Speaker:Hiroshi Nishihara(Genomics Unit, Keio Cancer Center, Keio University School of Medicine)
LS17 DAIICHI SANKYO COMPANY, LIMITED.L
- October 1st (Fri) 11:50~12:40(7th venue)PACIFICO Yokohama 3rd floor Room 311+312
- Chair:Yasuo Hamamoto(Keio University School of Medicine)
- Providing optimal treatment for cancer eradication: Focusing on total care including cancer pain treatment
- Speaker:Taroh Satoh(Frontier Sci. for Cancer & Chemother, Osaka University Graduate School of Medicine)
LS18Novartis Pharma K.K.L
- October 1st (Fri) 11:50~12:40(8th venue)PACIFICO Yokohama 3rd floor Room 313+314
- Chair:Toshinari Yamashita(Department of Breast and Endocrine Surgery, Kanagawa Cancer Center)
- Future Direction of Translational Research in Optimizing Breast Cancer Treatment Strategy
- Speaker:Yoichi Naito(Department of Medical Oncology, National Cancer Center Hospital East)
LS19AbbVie GK L
- October 1st (Fri) 11:50~12:40(9th venue)PACIFICO Yokohama 4rd floor Room 411+412
- Chair:Koichi Akashi(Kyushu University)
- Molecular Diagnosis and Target Therapy for Acute Myeloid Leukemia
- Speaker:Yamaguchi Hiroki(Nippon Medical School)
LS20 Nikon Corporation. O
- October 1st (Fri) 11:50~12:40(11th venue)PACIFICO Yokohama 4rd floor Room 414+415
- Chair:Yasujiro Kiyota (Nikon Corporation)
- Advanced T Cell Analytics Using Digital Cell Biology at Light Speed
- Speaker:Tina Kang(Berkeley Lights Inc.,)
LS21 MSD K. K. L
- October 1st (Fri) 11:50~12:40(12th venue)PACIFICO Yokohama 4rd floor Room 416+417
- Chair:Hisashi Wada(Osaka University, Clinical Research in Tumor Immunology)
- Targeting "a Triple Low" in the tumor microenvironment
- Speaker:Heiichiro Udono(Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences)
LS22 SBI Pharmaceuticals Co., Ltd. O
- October 1st (Fri) 11:50~12:40(13th venue)PACIFICO Yokohama 4rd floor Room 418
- Chair:Kenji Chamoto(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
- Cancer immunotherapy based on immune checkpoint inhibitors and mitochondrial regulation drugs
- Speaker 1:Kenji Chamoto(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
- 5-ALA/SFC enhanced effect of immune checkpoint inhibitor
- Speaker 2:Xiao-Kang Li(Division of Transplantation Immunology, National Research Institute for Child Health and Development)
- NK cell activation by 5-aminolevulinic acid
- Speaker 3:Motowo Nakajima(Division of Development, SBI Pharmaceuticals Co., Ltd.)
LS23 Nippon Boehringer Ingelheim Co., Ltd. L
- October 1st (Fri) 11:50~12:40(15th venue)PACIFICO Yokohama 5rd floor Room 501
- Chair:Kazuto Nishio(Department of Genome Biology, Kindai University Faculty of Medicine)
- Challenges and Prospects for Precision Medicine
- Speaker:Masayuki Takeda(Department of Cancer Genomics and Medical Oncology, Nara Medical University)
LS24 ONO PHARMACEUTICAL CO., LTD. / Bristol-Myers Squibb K.K. L
- October 1st (Fri) 11:50~12:40(16th venue)PACIFICO Yokohama 5rd floor Room 502
- Chair:Kenzo Soejima(Clinical and Translational Research Center, Keio University Hospital)
- Combined immunotherapy for advanced non-small cell lung cancer
- Speaker 1:Isamu Okamoto(Research Institute for Diseases of the Chest Graduate School of Medical Sciences Kyushu University)
- CTLA-4 blockade in antitumor immunity
- Speaker 2:Yosuke Togashi(Department of Tumor Microenvironment, Okayama University, Graduate School of Medicine Dentistry and Pharmaceutical Sciences)
LS25 Bayer Yakuhin, Ltd. L
- October 1st (Fri) 11:50~12:40(17th venue)PACIFICO Yokohama 5rd floor Room 511+512
- Chair:Hironobu Minami(Kobe University Graduate School of Medicine Oncology /Hematorogy)
- Current status and future outlook of cancer precision medicine in Japan
– A new strategy for the treatment of gene fusion-positive solid tumors – - Speaker:Shinji Kohsaka(Division of Cellular Signaling National Cancer Center Research Institute)
October 2nd (Sat)
LS26 Janssen Pharmaceutical K.K. L
- October 2nd(Sat) 11:50~12:40(Second venue)PACIFICO Yokohama 3rd floor Room 301
- Chair:Koichi Akashi(Department of Medicine and Biosystemic Science, Graduate School of Medical Science, Kyushu University)
- The fist-in-class anti-CD38 antibody daratumumab made a paradigm shift in the therapeutic landscape of multiple myeloma
- Speaker:Yusuke Furukawa(Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University)
LS27 Merck Biopharma Co., Ltd.L
- October 2nd(Sat) 11:50~12:40(Third venue)PACIFICO Yokohama 3rd floor Room 302
- Chair:Junji Tsurutani (Advanced Cancer Translational research institute, Showa University)
- Future Diagnostics for Precision Cancer Medicine; Genome x Pathology x AI = ?
- Speaker:Hiroshi Nishihara (Genomics Unit, Keio Cancer Center, Keio University School of Medicine)
LS28 MSD K. K.L
- October 2nd(Sat)11:50~12:40(4th venue)PACIFICO Yokohama 3rd floor Room 303
- Chair:Seiji Yano(Division of Medical Oncology, Cancer Research Institute, Kanazawa University)
- Recent advances in translational research for immune checkpoint inhibitors
- Speaker:Shohei Koyama(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center / Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine)
LS29 10x Genomics Inc. / SCRUM Inc.L
- October 2nd(Sat)11:50~12:40(5th venue)PACIFICO Yokohama 3rd floor Room 304
- Chair:Yutaka Suzuki(Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo)
- T cell clonal evolution in the tumor microenvironment elucidated by single-cell sequencing
- Speaker:Yosuke Togashi(Department of Tumor Microenvironment, Okayama University, Graduate School of Medicine Dentistry and Pharmaceutical Sciences)
LS30 Janssen Pharmaceutical K.K. / NIPPON SHINYAKU CO., LTD. L
- October 2nd(Sat) 11:50~12:40(7th venue)PACIFICO Yokohama 3rd floor Room 311+312
- Chair:Kazutaka Saito(Dokkyo Medical University Saitama Medical Center)
- Update on the treatment of metastatic prostate cancer based on mechanisms of therapeutic resistance
- Speaker 1:Daisuke Obinata(Nihon University School of Medicine, Department of Urology)
- Role of androgen receptor axis-targeted (ARAT) agents in diversifying prostate cancer treatments
- Speaker 2:Kohei Hashimoto(Sapporo Medical University School of Medicine Department of urology)
LS31 Merck Biopharma Co., Ltd. / Pfizer Japan Inc.
- October 2nd(Sat) 11:50~12:40(8th venue)PACIFICO Yokohama 3rd floor Room 313+314
- Chair:Hideaki Miyake(Department of Urology, Hamamatsu University School of Medicine)
- Cancer Immunotherapy in Urological Tumors
- Speaker :Shigehisa Kitano(Division of Cancer Immunotherapy Development Advanced Medical Development Center)
LS32 CANON MEDICAL SYSTEMS CORPORATION.L
- October 2nd(Sat) 11:50~12:40(9th venue)PACIFICO Yokohama 4rd floor Room 411+412
- Chair:Manabu Muto(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)
- New initiatives for genomic medicine at Kyoto University Hospital
- Speaker 1:Masashi Kanai(Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University New initiatives for genomic medicine at Kyoto University Hospital)
- Leveraging RWD can shift the future of cancer care.
- Speaker 2:Shigemi Matsumoto(Department of Real World Data R & D, Graduate School of Medicine, Kyoto University)
LS33 AS ONE Corporation.O
- October 2nd(Sat)11:50~12:40(11th venue)PACIFICO Yokohama 4rd floor Room 414+415
- Chair:Naoto Momoda(AS ONE Corporation)
- Introducing new spatial analysis technology: Quantitative image analysis by image-cytometry, and gene/protein-based hyperplex spatial profiling by index oligo-labeled probe.
- Speaker:Takashi Matsui(AS ONE Corporation)